American Research & Management Company Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.29M |
| 2 |
Helmerich & Payne
HP
|
+$704K |
| 3 |
PayPal
PYPL
|
+$644K |
| 4 |
Gilead Sciences
GILD
|
+$512K |
| 5 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
+$359K |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.69% |
| 2 | Healthcare | 14.97% |
| 3 | Consumer Staples | 13.1% |
| 4 | Miscellaneous | 10.52% |
| 5 | Financials | 9.47% |
Similar funds
American Research & Management Company's Q1 2017 Portfolio in Review
As of Q1 2017, American Research & Management Company held 374 positions worth $281M, down 3.7% from $292M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
American Research & Management Company withdrew a net $24.3M in Q1 2017, closing 35 positions and reducing 92 holdings. Its most notable exit was PrivateBancorp, Inc. Capital Trust IV Trust Preferred, an estimated $5.61M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Staples.
Against the trend, American Research & Management Company opened a new position in Bioverativ Inc. Common Stock worth $397K.
- American Research & Management Company's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 7,291 shares worth $397K.
- American Research & Management Company added most to NVIDIA in Q1 2017, an estimated $1.29M increase.
- American Research & Management Company's biggest Q1 2017 reduction was Allied World Assurance Co Hld Lt, cutting an estimated $3.73M.
- American Research & Management Company fully exited PrivateBancorp, Inc. Capital Trust IV Trust Preferred in Q1 2017, selling an estimated $5.61M.
- American Research & Management Company's ten largest holdings make up 40% of its $281M portfolio in Q1 2017.
- American Research & Management Company opened 13 new positions and closed 35 in Q1 2017.
- American Research & Management Company's portfolio value fell 3.7% quarter-over-quarter to $281M.
Based on American Research & Management Company's 13F filing for Q1 2017, filed 17 Apr 2017.